353 related articles for article (PubMed ID: 19380868)
1. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.
Sereti I; Dunham RM; Spritzler J; Aga E; Proschan MA; Medvik K; Battaglia CA; Landay AL; Pahwa S; Fischl MA; Asmuth DM; Tenorio AR; Altman JD; Fox L; Moir S; Malaspina A; Morre M; Buffet R; Silvestri G; Lederman MM;
Blood; 2009 Jun; 113(25):6304-14. PubMed ID: 19380868
[TBL] [Abstract][Full Text] [Related]
2. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.
Levy Y; Lacabaratz C; Weiss L; Viard JP; Goujard C; Lelièvre JD; Boué F; Molina JM; Rouzioux C; Avettand-Fénoêl V; Croughs T; Beq S; Thiébaut R; Chêne G; Morre M; Delfraissy JF
J Clin Invest; 2009 Apr; 119(4):997-1007. PubMed ID: 19287090
[TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study.
Lévy Y; Sereti I; Tambussi G; Routy JP; Lelièvre JD; Delfraissy JF; Molina JM; Fischl M; Goujard C; Rodriguez B; Rouzioux C; Avettand-Fenoël V; Croughs T; Beq S; Morre M; Poulin JF; Sekaly RP; Thiebaut R; Lederman MM
Clin Infect Dis; 2012 Jul; 55(2):291-300. PubMed ID: 22550117
[TBL] [Abstract][Full Text] [Related]
4. Phase 1 trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus-infected patients with 100-500 CD4 cells/microL.
Jacobson MA; Hardy D; Connick E; Watson J; DeBruin M
J Infect Dis; 2000 Oct; 182(4):1070-6. PubMed ID: 10979901
[TBL] [Abstract][Full Text] [Related]
5. Administration of interleukin-7 increases CD4 T cells in idiopathic CD4 lymphocytopenia.
Sheikh V; Porter BO; DerSimonian R; Kovacs SB; Thompson WL; Perez-Diez A; Freeman AF; Roby G; Mican J; Pau A; Rupert A; Adelsberger J; Higgins J; Bourgeois JS; Jensen SM; Morcock DR; Burbelo PD; Osnos L; Maric I; Natarajan V; Croughs T; Yao MD; Estes JD; Sereti I
Blood; 2016 Feb; 127(8):977-88. PubMed ID: 26675348
[TBL] [Abstract][Full Text] [Related]
6. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J
Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744
[TBL] [Abstract][Full Text] [Related]
7. IL-7 administration alters the CD4:CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation.
Geiselhart LA; Humphries CA; Gregorio TA; Mou S; Subleski J; Komschlies KL
J Immunol; 2001 Mar; 166(5):3019-27. PubMed ID: 11207251
[TBL] [Abstract][Full Text] [Related]
8. IL-7 stimulates T cell renewal without increasing viral replication in simian immunodeficiency virus-infected macaques.
Nugeyre MT; Monceaux V; Beq S; Cumont MC; Ho Tsong Fang R; Chêne L; Morre M; Barré-Sinoussi F; Hurtrel B; Israël N
J Immunol; 2003 Oct; 171(8):4447-53. PubMed ID: 14530372
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation.
Perales MA; Goldberg JD; Yuan J; Koehne G; Lechner L; Papadopoulos EB; Young JW; Jakubowski AA; Zaidi B; Gallardo H; Liu C; Rasalan T; Wolchok JD; Croughs T; Morre M; Devlin SM; van den Brink MR
Blood; 2012 Dec; 120(24):4882-91. PubMed ID: 23012326
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-4 downregulates CD127 expression and activity on human thymocytes and mature CD8+ T cells.
Crawley AM; Vranjkovic A; Young C; Angel JB
Eur J Immunol; 2010 May; 40(5):1396-407. PubMed ID: 20201040
[TBL] [Abstract][Full Text] [Related]
12. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets.
Sportès C; Hakim FT; Memon SA; Zhang H; Chua KS; Brown MR; Fleisher TA; Krumlauf MC; Babb RR; Chow CK; Fry TJ; Engels J; Buffet R; Morre M; Amato RJ; Venzon DJ; Korngold R; Pecora A; Gress RE; Mackall CL
J Exp Med; 2008 Jul; 205(7):1701-14. PubMed ID: 18573906
[TBL] [Abstract][Full Text] [Related]
13. Treatment with IL-7 prevents the decline of circulating CD4+ T cells during the acute phase of SIV infection in rhesus macaques.
Vassena L; Miao H; Cimbro R; Malnati MS; Cassina G; Proschan MA; Hirsch VM; Lafont BA; Morre M; Fauci AS; Lusso P
PLoS Pathog; 2012; 8(4):e1002636. PubMed ID: 22511868
[TBL] [Abstract][Full Text] [Related]
14. CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection.
Dunham RM; Cervasi B; Brenchley JM; Albrecht H; Weintrob A; Sumpter B; Engram J; Gordon S; Klatt NR; Frank I; Sodora DL; Douek DC; Paiardini M; Silvestri G
J Immunol; 2008 Apr; 180(8):5582-92. PubMed ID: 18390743
[TBL] [Abstract][Full Text] [Related]
15. Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Ralpha on central and effector memory CD4+ and CD8+ T cell subsets.
Mercier F; Boulassel MR; Yassine-Diab B; Tremblay C; Bernard NF; Sekaly RP; Routy JP
Clin Exp Immunol; 2008 Apr; 152(1):72-80. PubMed ID: 18279439
[TBL] [Abstract][Full Text] [Related]
16. Treatment with Interleukin-7 Restores Host Defense against Pneumocystis in CD4+ T-Lymphocyte-Depleted Mice.
Ruan S; Samuelson DR; Assouline B; Morre M; Shellito JE
Infect Immun; 2016 Jan; 84(1):108-19. PubMed ID: 26483405
[TBL] [Abstract][Full Text] [Related]
17. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.
Kaufmann GR; Zaunders JJ; Cunningham P; Kelleher AD; Grey P; Smith D; Carr A; Cooper DA
AIDS; 2000 Dec; 14(17):2643-51. PubMed ID: 11125882
[TBL] [Abstract][Full Text] [Related]
18. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
Gray CM; Schapiro JM; Winters MA; Merigan TC
AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells.
Di Caro V; D'Anneo A; Phillips B; Engman C; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N
Clin Exp Immunol; 2011 Jul; 165(1):60-76. PubMed ID: 21413939
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool.
Melchionda F; Fry TJ; Milliron MJ; McKirdy MA; Tagaya Y; Mackall CL
J Clin Invest; 2005 May; 115(5):1177-87. PubMed ID: 15841203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
